FibroGen sells China unit to AstraZeneca for $160 million
26.89MUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US31572Q8087
CUSIP
31572Q808
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
-53.66
Dividend Share
-
Dividend Yield
-
Earnings Share
-26.52
Wall Street Target Price
250.00
EPS Estimate Current Year
-12.13
EPS Estimate Next Year
-18.13
EPS Estimate Current Quarter
0.02
EPS Estimate Next Quarter
-0.22
Most Recent Quarter
-
Revenue TTM
6,996,000
Gross Profit TTM
-55,852,000
EBITDA
-94,375,000
Profit Margin
-143.04%
Return On Assets TTM
-22.73%
Return On Equity TTM
-1015.79%
Revenue Per Share TTM
1.74
Qtly Revenue Growth YOY
-89.20%
Diluted Eps TTM
-26.52
Qtly Earnings Growth YOY
53.60%
Trailing PE
0.00
Forward PE
61
Price Sales TTM
84.9255
Price Book MRQ
53.8258
Enterprise Value Revenue
9
Enterprise Value EBITDA
0
313.25
1.42%447.01
1.13%512.11
0.63%542.04
0.24%586.54
0.00%90.46
-3.20%190.02
-2.85%148.56
-1.54%252.80
-0.50%78.18
-0.37%FibroGen sells China unit to AstraZeneca for $160 million
#earnings after the close https://t.co/lObOE0dgsr $AMC $APPS $PRPL $DDD $CHGG $SDC $ELY $INO $NTR $HALO $REAL $LOTZ $CF $PLNT $SAIL $HBM $PRTK $ETH $ADMS $NLS $CBT $AEMD $ACM $GOSS $WES $RPAY $API $MESA $WTRH $STE $APPF $BARK $DOOR $FGEN $ADAP $ORGO $ATCO $ARCT $CMP $NGL $LU https://t.co/AePy0Mp5xb
See which Billionaires own this investment